Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1778155
Max Phase: Preclinical
Molecular Formula: C40H75NO14
Molecular Weight: 794.03
Molecule Type: Small molecule
Associated Items:
ID: ALA1778155
Max Phase: Preclinical
Molecular Formula: C40H75NO14
Molecular Weight: 794.03
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)CC(C)(C)O)[C@H]2O)[C@](C)(O)C[C@@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@]1(C)O
Standard InChI: InChI=1S/C40H75NO14/c1-15-27-40(12,49)32(44)22(4)29(42)20(2)17-38(10,48)34(55-36-30(43)26(16-21(3)51-36)41(13)19-37(8,9)47)23(5)31(24(6)35(46)53-27)54-28-18-39(11,50-14)33(45)25(7)52-28/h20-34,36,42-45,47-49H,15-19H2,1-14H3/t20-,21-,22+,23+,24-,25+,26+,27-,28+,29+,30-,31+,32-,33+,34-,36+,38-,39-,40-/m1/s1
Standard InChI Key: RFKAUOGLAMBBCJ-IIIUCYNOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 794.03 | Molecular Weight (Monoisotopic): 793.5188 | AlogP: 1.72 | #Rotatable Bonds: 9 |
Polar Surface Area: 217.30 | Molecular Species: BASE | HBA: 15 | HBD: 7 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.45 | CX Basic pKa: 9.50 | CX LogP: 1.93 | CX LogD: -0.17 |
Aromatic Rings: 0 | Heavy Atoms: 55 | QED Weighted: 0.17 | Np Likeness Score: 1.62 |
1. Liu Y, Carreras CW, Claypool M, Myles DC, Shaw SJ.. (2011) The role of the 4''-hydroxyl on motilin agonist potency in the 9-dihydroerythromycin series., 21 (12): [PMID:21570844] [10.1016/j.bmcl.2011.04.078] |
Source(1):